Showing results (41-50 of 146) with videos related to
Sort By:
Pageof 15
Seminars in Oncology|October 19, 2006
The current role of angiogenesis inhibitors in the treatment of renal cell carcinomaToni K Choueiri, Ronald M Bukowski, Brian I RiniAdvances in Therapy|July 13, 2010
Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumorsHiu-yan Chan, Ashley B Grossman, Ronald M BukowskiClinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2010
Biomarkers predicting outcome in patients with advanced renal cell carcinoma: Results from sorafenib phase III Treatment Approaches in Renal Cancer Global Evaluation TrialCarol Peña, Chetan Lathia, Minghua Shan, et al.Current Oncology Reports|February 19, 2005
Novel vascular targeting/disrupting agents: combretastatin A4 phosphate and related compoundsMatthew M Cooney, Jose Ortiz, Ronald M Bukowski, et al.Cancer|July 19, 2002
Treating cancer with PEG Intron: pharmacokinetic profile and dosing guidelines for an improved interferon-alpha-2b formulationRonald M Bukowski, Craig Tendler, David Cutler, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Skeletal complications in patients with bone metastases from renal cell carcinoma and therapeutic benefits of zoledronic acidAllan Lipton, Alejandro Colombo-Berra, Ronald M Bukowski, et al.Current Oncology Reports|February 14, 2003
New and modified interferon alfas: preclinical and clinical dataPaul Masci, Ronald M Bukowski, Phillip A Patten, et al.Investigational New Drugs|July 22, 2005
Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinomaPhilip E Shaheen, Walter Stadler, Paul Elson, et al.Clinical Genitourinary Cancer|July 25, 2006
Adjuvant subcutaneous interleukin-2 in patients with resected renal cell carcinoma: a pilot studyNavneet S Majhail, Laura Wood, Paul Elson, et al.Investigational New Drugs|June 10, 2006
Phase 1 trial of Anvirzel in patients with refractory solid tumorsTarek Mekhail, Hanspreet Kaur, Ram Ganapathi, et al.Pageof 15